Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: Region specific adaptation after fluoxetine treatment

Molecular Brain Research

Volumn 59, Issue 1, 1998, Pages 58-65

  Caberlotto, Laura ^a,b   Fuxe, Kjell ^a   Overstreet, David H ^c   Gerrard, Philip ^d   Hurd, Yasmin L ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d GSK   (Italy)

Author keywords

Depression; Flinders sensitive line rats; Fluoxetine; Genetic rat model; In situ hybridization; Neuropeptide Y receptor

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN RECEPTOR; FLUOXETINE; MESSENGER RNA; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BRAIN; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; GENE EXPRESSION; GENE INDUCTION; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSION; FLUOXETINE; IN SITU HYBRIDIZATION; LIMBIC SYSTEM; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS;

ANIMALIA;

EID: 0032528934     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00137-5     Document Type: Article

References (44)

1. J.P. Aggleton, The contribution of the amygdala to normal and abnormal emotional states, Trends Neurosci. 16 (1993) 328-333.
2. R.A. Baker, M. Herkenham, L.S. Brady, Effects of long-term treatment with antidepressant drugs on proopiomelanocortin and neuropeptide Y mRNA expression in the hypothalamic arcuate nucleus of rats, J. Neuroendocrinol. 8 (1996) 337-343.
3. R. Bellmann, G. Sperk, Effects of antidepressant treatment on levels of NPY or prepro-NPY-mRNA in the rat brain, Neurochem. Int. 22 (1993) 183-187.
4. W.W. Blessing, P.R.C. Howe, T.H. Joh, J.R. Oliver, J.O. Willoghby, Distribution of tyrosine hydroxylase and neuropeptide Y-like immunoreactive neurons in rabbit medulla oblongata, with attention to colocalization studies, presumptive adrenaline-synthesizing perikarya, and vagal preganglionic cells, J. Comp. Neurol. 248 (1986) 285-300.
5. S.C. Cheetham, M.R. Crompton, C.L. Katona, R.W. Horton, Brain 5-HT1 binding sites in depressed suicides, Psychopharmacology 102 (1990) 544-548.
6. M. Davis, D. Rainnie, M. Cassell, Neurotransmission in the rat amygdala related to fear and anxiety, Trends Neurosci. 17 (1994) 208-214.
7. S. Dryden, H.M. Frankish, Q. Wang, L. Pickavance, G. Williams, The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats, Neuroscience 72 (1996) 557-566.
8. B.J. Everitt, T. Hökfelt, L. Terenius, K. Tatemoto, V. Mutt, M. Goldstein, Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat, Neuroscience 11 (1984) 443-462.
9. E.P. Finta, J.T. Regenold, P. Hies, Depression by neuropeptide Y of noradrenergic inhibitory postsynaptic potentials of locus coeruleus neurones, Naunyn-Schmiedebergs Arch. Pharmacol. 346 (1992) 472-474.
10. J.F. Flood, E.N. Hernandez, J.E. Morley, Modulation of memory processing by Neuropeptide Y, Brain Res. 421 (1987) 280-290.
11. F.H. Gawin, H.D. Kleber, Abstinence symptomology and psychiatric diagnosis in cocaine abusers, Arch. Gen. Psych. 43 (1989) 107-113.
12. A. Gjerris, E. Widerlöv, L. Werdelin, R. Ekman, Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls, J. Psichiatr. Neurosci. 17 (1992) 23-27.
13. E.L. Gustafson, S. K.E., M.M. Durkin, M.W. Walker, C. Gerarld, R. Wenshank, T. Branchek, Distribution of neuropeptide Y Y2 receptor mRNA in rat central nervous system, Mol. Brain Res. 46 (1997) 223-235.
14. H. Hashimoto, H. Onishi, S. Koide, T. Kai, S. Yamagami, Plasma neuropeptide Y in patients with major depressive disorder, Neurosci. Lett. 216 (1996) 57-60.
15. M. Heilig, C. Wahlestedt, R. Ekman, E. Widerlöv, Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain, Eur. J. Pharmac. 147 (1988) 465-467.
16. Y.L. Hurd, M. Herkenham, Molecular alterations in the neostriatum of human cocaine addicts, Synapse 13 (1993) 357-369.
17. J. Hänze, W. Kummer, M.L. Haass, R.E. Haass, Neuropeptide Y mRNA regulation in rat sympathetic ganglia: effect of reserpine, Neurosci. Lett. 124 (1991) 119-121.
18. D.S. Janowski, M.K. El-Yousef, J.M. Davis, H.J. Sekerke, A cholinergic-adrenergic hypothesis of mania and depression, Lancet 2 (1972) 632-635.
19. H.M. Lachman, D.F. Papolos, E.D. Weiner, R. Ramazankhana, C. Hartnick, E. Edwards, F.A. Henn, Hippocampal neuropeptide Y mRNA is reduced in a strain of learned helpless resistant rats, Mol. Brain Res. 14 (1992) 94-100.
20. P.J. Larsen, S.P. Sheikh, C.R. Jakobsen, T.W. Scwartz, J.D. Mikkelsen, Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system, Eur. J. Neurosci. 5 (1993) 1622-1637.
21. B.E. Leonard, The olfactory bulbectomized rat as a model of depression, Pol. J. Pharmacol. Pharm. 36 (1984) 561-569.
22. M. Martire, G. Pistritto, N. Mores, L.F. Agnati, K. Fuxe, Region-specific inhibition of potassium evoked [3H] noradrenaline release from rat brain synaptosomes by neuropeptide Y of the Y2 type, Eur. J. Pharmacol. 230 (1993) 231-234.
23. A.A. Mathé, S. Gruber, P.A. Jimenez, E. Theodorsson, C. Stenfors, Effect of electroconvulsive stimuli and MK-801 on neuropeptide Y, neurokinin A, and calcitonin gene-related peptide in rat brain, Neurochem. Res. 22 (1997) 629-636.
24. A.A. Mathé, M.V. Rudorfer, C. Stenfors, H.K. Manji, W.C. Potter, E. Theodorsson, Effect of electroconvulsive treatment on somatostatin, neuropeptide Y, endothelin and neurokinin A concentrations in cerebrospinal fluid of depressed patients, Depression 3 (1996) 250-256.
25. J.D. Mikkelsen, D. Woldbye, J. Kragh, P. Larsen, T.G. Bolwig, Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and the dentate gyrus, Mol. Brain Res. 23 (1994) 317-322.
26. B.J. Morris, Neuronal localisation of neuropeptide Y gene expression in rat brain, J. Comp. Neurol. 290 (1989) 358-368.
27. G.A. Ordway, C.A. Stockmeier, H.Y. Meltzer, J.C. Ocerholser, S. Jaconetta, P.S. Widdowson, Neuropeptide Y in frontal cortex is not altered in major depression, J. Neurochem. 65 (1995) 1646-1650.
28. D.H. Overstreet, The Flinders sensitive line rats: an animal model of depression, Neurosci. Biobehav. Rev. 17 (1993) 51-68.
29. D.H. Overstreet, R.W. Russel, Selective breeding for sensitivity to DFP. Effects of cholinergic agonists and antagonists, Psychopharmacology 78 (1982) 150-154.
30. D.H. Overstreet, R.W. Russel, S.C. Helps, M. Messenger, Selective breeding for the sensitivity to the anticholinesterase, DFP, Psychopharmacology 64 (1979) 15-20.
31. G. Paxinos, C. Watson, The rat brain in stereotaxic coordinates, Academic Press, New York, 1982.
32. O. Pucilowski, D.H. Overstreet, A.H. Rezvani, D.S. Janowski, Chronic mild stress-induced anhedonia: greater effect in a genetic animal model of depression, Physiol. Behav. 54 (1993) 1215-1220.
33. E. Schlicker, G. Gross, K. Fink, T. Glaser, M. Gothert, Serotonin release in the rat brain cortex is inhibited by neuropeptide Y but not affected by ACTH1-24, angiotensin II, Bradykinin and delta-sleep-inducing peptide, Naunyn-Schmiedebergs Arch. Pharmacol. 343 (1991) 117-122.
34. P.J. Shiromani, D.H. Overstreet, D. Levy, C.A. Goodrich, S.S. Campbell, J.C. Gillin, Increased REM sleep in rats selectively bred for cholinergic hyperactivity, Neuropsychopharmacology 1 (1988) 127-133.
35. M. Smialowska, B. Legutko, Influence of imipramine on neuropeptide Y immunoreactivity in the rat brain, Neuroscience 41 (1991) 767-771.
36. C. Stenfors, E. Theodorsson, A.A. Mathé, Effect of repeated electroconvulsive treatment on regional concentrations of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y and galanin in rat brain, J. Neurosci. Res. 24 (1989) 445-450.
37. C. Wahlestedt, J.A. Blendy, K.J. Kellar, M. Heilig, E. Widerlöv, R. Ekman, Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immuno-reactivity in the rat, Brain Res. 507 (1990) 65-68.
38. C. Wahlestedt, F. Karoum, G. Jaskiw, R. Jed Wyatt, D. Larhammar, R. Ekman, D.J. Reis, Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 2078-2082.
39. E.D. Weiner, A. Mallat, D.F. Papolos, H.M. Lachman, Acute lithium treatment enhances neuropeptide Y gene expression in rat hippocampus, Mol. Brain Res. 12 (1992) 209-214.
40. P.S. Widdowson, A.E. Halaris, Increased levels of neuropeptide Y-immunoreactivity in rat brain limbic structures following antidepressant treatment, J. Neurochem. 52 (1989) S77, (supp.).
41. P.S. Widdowson, G.A. Ordway, A.E. Halaris, Reduced Neuropeptide Y concentrations in suicide brain, J. Neurochem. 59 (1992) 73-80.
42. E. Widerlöv, M. Heilig, R. Ekman, C. Wahlestedt, Possible relationship between neuropeptide Y (NPY) and major depression-evidence from human and animal studies, Nord. Psykiatr. Tidsskr. 42 (1988) 131-137.
43. E. Widerlöv, L.H. Lindström, C. Wahlestedt, R. Ekman, Neuropeptide Y and peptide YY as possible cerebrospinal markers for major depression and schizophrenia respectively, J. Psichiatr. Res. 22 (1988) 69-79.
44. A. Zangen, D.H. Overstreet, G. Yadid, High serotonin and 5-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: Normalization by chronic antidepressant treatment, J. Neurochem. 69 (1997) 2477-2483.